Psoriasis Clinical Trial
IMPACT – AndHealth Autoimmune Research Registry
This is a patient research registry aimed at evaluating the effectiveness of a comprehensive, root-cause medical approach ("AndHealth program") for autoimmune disorders. This approach involves a combination of pharmacological and non-pharmacological therapies offered under the care of a licensed physician with the support of health coaches. While protocol guidance is provided, the therapeutic approach is personalized to the individual needs of patients. The autoimmune disorders of focus in this registry include rheumatoid arthritis, psoriatic arthritis, psoriasis and ankylosing spondylitis. A variety of validated labs, patient-reported outcomes, and medication usage will be assessed among participating patients over a period of up to five years to evaluate the long-term effectiveness of this approach.
Adults 18 to 70 years of age
Able to understand and write English
Voluntarily consent to the study and understand its nature and purpose including potential risks and side effects
Documented diagnosis and current use/recommendation for biologic or DMARD medications to treat rheumatoid arthritis, psoriatic arthritis, psoriasis, or ankylosing spondylitis.
Pregnant, breastfeeding, or planning to become pregnant in the next 12 months
Advanced liver or kidney disease
Previous organ transplant or awaiting organ transplant
Actively being treated for cancer
Poorly-controlled mental illness (i.e., schizophrenia, bipolar, current eating disorder)
Has a terminal illness
Current opioid use
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.